Dr. Shawn Zimberg

Shawn H. Zimberg, MD

National Director of Radiation Oncology Services

Dr. Shawn Zimberg is National Director of Radiation Oncology Services for Solaris Health Partners. He is also the founding partner and Medical Director of Advanced Radiation Centers of New York (ARCNY).

He is a board-certified radiation oncologist with expertise in head and neck, breast, lung and gastrointestinal cancers with significant specialization in the treatment of prostate cancer.  He and his colleagues at ARC currently treat more prostate cancer patients with fiducial-based based Image Guided Volumetric Modulated Arc Therapy (IG-VMAT) than any other facility in the metropolitan New York area, if not the entire country.

For the last several decades, Dr. Zimberg has been a leader in the deployment of the most sophisticated Radiation Oncology technologies in the world, including IGRT and RapidArc Rotational Radiation Therapy, pioneering the clinical use of these modalities for brain, lung, head & neck and prostate cancer treatments.   He and his colleagues were the first on the East Coast and the fourth facility in the world to treat a patient using RapidArc (VMAT) technology. In addition, Dr. Zimberg was one of the first physicians in the New York area to utilize Intensity Modulated Radiation Therapy (IMRT) in the treatment of breast cancer, a technology that decreases radiation exposure to the lung and heart.   He and his colleagues at ARC were also the first in the area to use the Mammosite and SAVI breast applicators for partial breast irradiation (PBI).  He has been a leader in community-based use of stereotactic body radiotherapy for early stage lung cancers.

Dr. Zimberg received his MD from the University of Michigan Medical School, and completed his radiation oncology residency training at Memorial Sloan-Kettering Cancer Center in NYC, where as a senior resident, he was received the American Cancer Society’s Clinical Fellowship award.

Dr. Zimberg has numerous peer-reviewed medical journal publications ranging from new technologies in the treatment of prostate cancer to medical economics of large group practice, and has been a principal investigator in clinical trials including several FDA pivotal trials evaluating cutting-edge technologies in cancer care.  He regularly lectures before both community and medical audiences on topics including prostate, breast, colorectal and lung cancers, and has been featured as a medical expert in television, radio and newspaper reports on cancer, featured in publications and programs including The New York Times, The Wall Street Journal, ABC News and locally News 12 Long Island and the Telecare network.  He has been an invited faculty speaker at the MD Anderson Cancer Center’s Annual Updates in Oncology Conference.  As a known leader in cancer care and technologies, Dr. Zimberg is a current member of the Scientific Advisory Board of Evolution Ventures, an investment firm which focuses on biotechnology, including oncology and cancer breakthroughs.

Dedicated to the communities he and his colleagues serve,  Dr. Zimberg has served on the Board of Advisors for the Nassau County Chapter of the American Cancer Society including several years as their Medical Spokesman.   He has received numerous awards including distinguished honoree from the Beth C. Tortolani Foundation, the American Cancer Society, the Integrated Medical Foundation and the Lean-On-Me Breast Cancer Network for his work and dedication to the fight against cancer.   As in years past, in 2021 he was again listed in Castle Connolly Regional Top Doctors, Newsday’s Top Doctors on Long Island, and New York Magazine’s Top Doctors.